Investigating efficacy of “microbiota modulation of the gut-lung Axis” combined with chemotherapy in patients with advanced NSCLC: study protocol for a multicenter, prospective, double blind, placebo controlled, randomized trial | BMC Cancer User montaukwhaler, in the non small cell lung cancer subreddit, 30 Jun 2021